Location: Quebec City, Ottawa, Hamilton, Vancouver
Sponsor: Population Health Research Institute
Sex: All
Age: 35 - 70
Code: NCT03225586
Recruiting
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
for
Bladder Cancer, Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06040762
Recruiting
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 0 - 70+
Code: NCT00001160
Recruiting
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05092373
Phase1, Recruiting
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
for
Non-Medullary Thyroid Cancer
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 7 - 70+
Code: NCT01109420
Recruiting
A Multicenter Cancer Biospecimen Collection Study
for
Cancer of Head and Neck, Lung Cancer, Nonsmall Cell,
Location: San Francisco CA
Sponsor: Cofactor Genomics, Inc.
Sex: All
Age: 18+
Code: NCT04510129
Recruiting
A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers
for
Head and Neck Cancer
Location: Boston MA, Houston TX
Sponsor: Foundation for the National Institutes of Health
Sex: All
Age: 18+
Code: NCT01936376
Recruiting
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
for
Cutaneous Squamous Cell Carcinoma, Skin Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07426484
Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Atlanta GA,